Philip Lee advised Novellus on the deal. Brooklyn ImmunoTherapeutics has completed its acquisition of engineered cellular medicine company Novellus Therapeutics Limited. This acquisition advances Brooklyn’s evolution...
Philip Lee advised Novellus on the deal. Brooklyn ImmunoTherapeutics has completed its acquisition of engineered cellular medicine company Novellus Therapeutics Limited. This acquisition advances Brooklyn’s evolution...
You must be a Standard 1 Year member to access this content.